Science, technology and culture gif


Our investor proposition

GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.

Trust and our long-term performance

Emma Walmsley, CEO, will speak at CECP’s CEO Investor Forum on 20 September 2018 at 10:30am EDT. She will talk about the steps we are taking to build trust – one of our three long-term priorities – and drive sustainable business performance.

Join the webcast

Latest information

Second quarter 2018 results and R&D update

We announced our second quarter 2018 results for the period ended 30 June 2018 and R&D update on Wednesday 25 July.

Find out more